Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Buckley
Adrian Buckley, Tracy CA
| Patent application number | Description | Published |
|---|---|---|
| 20110194547 | APPARATUS, AND ASSOCIATED METHOD, FOR FACILITATING WLAN SELECTION BY A MOBILE NODE - Apparatus, and an associated method, by which to facilitate selection of a WLAN through which a mobile node communicates. Selection takes into account the geographic positioning of the mobile node. The mobile node ascertains its geographic positioning by monitoring cellular-positioning signals. And, availability of WLANs through which to communicate is ascertained by detecting signals broadcast by the WLANs. | 08-11-2011 |
Bruce Bary Buckley, Bankok TH
| Patent application number | Description | Published |
|---|---|---|
| 20100064409 | SHAPE ENHANCING GARMENT - A shape enhancing garment to be worn upon a wearers body for the purpose of increasing or enhancing a visual buttock profile of the wearer is described. The shape enhancing garment is characterised in that it includes an outer rear fabric portion and an inner rear fabric portion arranged in an overlying manner. The shape enhancing garment further includes a first pocket and a second pocket, each pocket located upon an inner surface of the inner rear fabric portion. Each pocket is arranged to receive a shape defining pad and to retain the shape defining pad therein such that, in use, each shape defining pad is disposed adjacent a buttock of the wearer so as to create a visual buttock profile that is enhanced. A shape defining pad for use in a shape defining garment is also described, as is a method of manufacture of said shape defining pad. | 03-18-2010 |
Conor Buckley, Youghal IE
| Patent application number | Description | Published |
|---|---|---|
| 20120070537 | PROCESS FOR THE MANUFACTURE OF CHEESE - The present invention relates to an improved process for the manufacture of cheese, in particular hard and semi-hard cheese types. There is provided a process for the manufacture of a natural cheese comprising the steps of inoculating milk with a bacterial starter culture, adding rennet to form a curd, and subjecting the curd to a salting step by the addition of salt wherein a hydrocolloid or mixture thereof is added to the curd during the salting step and the hydrocolloid or mixture thereof replaces at least part of the salt or is in addition to the salt used during the salting step. There is also provided the use of such a salt and hydrocolloid mixture as a process aid during the salting step of natural cheese production. | 03-22-2012 |
Conor Buckley, Cork IE
| Patent application number | Description | Published |
|---|---|---|
| 20080274232 | Process for the Manufacture of Cheese - The present invention relates to an improved process for the manufacture of cheese, in particular hard and semi-hard cheese types. There is provided a process for the manufacture of a natural cheese comprising the stops of inoculating milk with a bacterial starter culture, adding rennet to form a curd, and subjecting the curd to a salting step by the addition of salt wherein a hydrocolloid or mixture thereof is added to the curd during the salting step and the hydrocolloid or mixture thereof replaces at least part of the salt or is in addition to the salt used during the salting step. There is also provided the use of such a salt and hydrocolloid mixture as a process aid during the salting step of natural cheese production. | 11-06-2008 |
George Martin Buckley, Berkshire UK
| Patent application number | Description | Published |
|---|---|---|
| 20100137302 | Fused Thiazole Derivatives as Kinase Inhibitors - A series of 6,7-dihydro[1,3]thiazolo[5,4-c]pyridin-4(5H)-one derivatives, and analogues thereof, which are substituted in the 2-position by an optionally substituted morpholin-4-yl moiety, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions. | 06-03-2010 |
James Thomas Buckley, Victoria CA
| Patent application number | Description | Published |
|---|---|---|
| 20100233191 | Method of treating or preventing benign prostatic hyperplasia using modified pore-forming proteins - The present invention provides a method of treating BPH using modified pore-forming proteins (MPPs). These MPPs are derived from naturally occurring cytotoxic proteins (nPPs) that kill cells by forming pores or channels in the cell membrane, resulting in cell death. The MPPs are generated by modification of the nPPs such that they are capable of being selectively activated at normal prostate cells. Such modification may include the addition of a prostate-specific protease cleavage site to the activation sequence, and/or the addition of a prostate-specific targeting domain to allow selective targeting of prostate cells. These MPPs are capable of selectively targeting and killing normal prostate cells in vivo. The MPPs may be used either alone or in combination with other therapies for the treatment of BPH. | 09-16-2010 |
Jonathan David Buckley, South Australia AU
| Patent application number | Description | Published |
|---|---|---|
| 20090298767 | FORMULATION COMPRISING WHEY PROTEIN AND HYDROLYSATES FOR IMPROVING MUSCLE RECOVERY - The present invention relates to a formulation comprising whey protein or a hydrolysate of whey protein, which formulation is capable of inhibiting the expression of TNFα in lipopolysaccharide-stimulated macrophages in vitro. Also provided are uses of the formulation for attenuating a reduction in muscle function which results from muscle damage and/or for enhancing recovery from muscle damage and/or for enhancing the force generating capacity of muscle and methods of making the formulation. | 12-03-2009 |
J. Thomas Buckley, Victoria CA
| Patent application number | Description | Published |
|---|---|---|
| 20090016988 | Modified Pore-Forming Protein Toxins and Use Thereof - The present invention provides modified pore-forming protein toxins (MPPTs), capable of being used to kill cancer cells. The MPPTs according to the present invention comprise a modification of the naturally occurring activation sequence comprising one or more general cleavage sites, each of which is cleavable by general activating agent, or a plurality of specific cleavage sites, each of which is cleavable by a specific activating agent. Optional further modifications that allow specific targeting of these molecules are also described. These MPPTs may be used to treat cancer. | 01-15-2009 |
| 20100234300 | PROAEROLYSIN CONTAINING PROTEASE ACTIVATION SEQUENCES AND METHODS OF USE FOR TREATMENT OF PROSTATE CANCER - Disclosed herein are modified proaerolysin (PA) peptide. In some examples, the proteins include a prostate-specific protease cleavage site and can further include a prostate-tissue-specific binding domain which functionally replaces the native PA binding domain. In other examples, the proteins include a furin cleavage site and a prostate tissue-specific binding domain which functionally replaces the native PA binding domain. Methods of using such peptides to treat prostate cancer are also disclosed. | 09-16-2010 |
Julien Buckley, Grenoble FR
| Patent application number | Description | Published |
|---|---|---|
| 20100124791 | METHOD TO FABRICATE A CHIP FOR THE DETECTION OF BIOLOGICAL ELEMENTS - Improved method to fabricate a microelectronic device provided with at least one circuit to detect biological elements, comprising the steps of: | 05-20-2010 |
Mark David Buckley, Buchendorf DE
| Patent application number | Description | Published |
|---|---|---|
| 20080251078 | Systems and methods for visualizing pressures and pressure responses to sleep-related triggering events - Systems and methods for visualizing patient treatment data collected while a patient suffering from sleep-disordered breathing is treated are provided. For example, according to certain example embodiments, a PAP device for treating a patient suffering from sleep-disordered breathing is provided. A processor may be set or programmed to generate a signal indicative of a triggering event. A flow generator may be configured to provide a supply of pressurized breathable gas to the patient based at least in part on the signal. Recording programmed logic circuitry may be provided to record in a data log pressures provided during patient treatment and triggering events occurring during patient treatment. Visualizing programmed logic circuitry in communication with the PAP device may be configured to read the data log and generate a visual depiction of provided pressures over time. Triggering events may include, for example, one or more of apnea, hypopnea, flattening, snore, etc. | 10-16-2008 |
| 20110284003 | MECHANICAL VENTILATION IN THE PRESENCE OF SLEEP DISORDERED BREATHING - A method for controlling operation of a CPAP apparatus. The apparatus has a blower, a patient interface, an air delivery conduit for delivering air from the blower to the patient interface, a sensor for determining the pressure in the patient interface, and a control mechanism that causes air to be delivered at a desired pressure to the patient interface and that detects transitions between inhalation and exhalation of a respiratory cycle of a patient in order to synchronise the blower output with the patient's efforts. In one form the CPAP apparatus provides pressure in accordance with a bi-level waveform with at least one characterising parameter of the waveform being automatically adjusted in accordance with indications of sleep disordered breathing. The indications of sleep disordered breathing can be one or more of snoring, apnea, hypopnea, and flow limitation. | 11-24-2011 |
Mark David Buckley, Munich DE
| Patent application number | Description | Published |
|---|---|---|
| 20090120437 | Flow Generator Message System - A flow generator for delivering breathable gas to a patient includes a processor coupled with operation sensors and a user interface. The processor is programmed to generate at least one of time-based or event-based messages relating to at least one of flow generator operation, flow generator service, flow generator use, patient health, peripheral devices and services, patient treatment, and reminders. Time-based messages are generated at predetermined time intervals based on either time of use or elapsed time. The event-based messages are generated based on signals from the operation sensors. The user interface is configured to deliver the messages to at least one of a display, a flow generator service provider, the patient and a physician. By this system, operation of the flow generator is facilitated and enhanced. | 05-14-2009 |
Naomi Buckley, Roscam IE
| Patent application number | Description | Published |
|---|---|---|
| 20120136344 | NEUROMODULATION CRYOTHERAPEUTIC DEVICES AND ASSOCIATED SYSTEMS AND METHODS - Neuromodulation cryotherapeutic devices and associated systems and methods are disclosed herein. A cryotherapeutic device configured in accordance with a particular embodiment of the present technology can include an elongated shaft having distal portion and a supply lumen along at least a portion of the shaft. The shaft can be configured to locate the distal portion intravascularly at a treatment site proximate a renal artery or renal ostium. The supply lumen can be configured to receive a liquid refrigerant. The cryotherapeutic device can further include a cooling assembly at the distal portion of the shaft. The cooling assembly can include an applicator in fluid communication with the supply lumen and configured to deliver cryotherapeutic cooling to nerves proximate the target site when the cooling assembly is in a deployed state. | 05-31-2012 |
Naomi Buckley, Galway IE
| Patent application number | Description | Published |
|---|---|---|
| 20120089047 | CRYOABLATION APPARATUSES, SYSTEMS, AND METHODS FOR RENAL NEUROMODULATION - Catheter apparatuses, systems, and methods for cryogenically modulating neural structures of the renal plexus by intravascular access are disclosed herein. One aspect of the present application, for example, is directed to apparatuses, systems, and methods that incorporate a catheter treatment device comprising an elongated shaft. The elongated shaft is sized and configured to deliver a cryo-applicator to a renal artery via an intravascular path. Cryogenic renal neuromodulation may be achieved via application of cryogenic temperatures to modulate neural fibers that contribute to renal function, or of vascular structures that feed or perfuse the neural fibers. | 04-12-2012 |
| 20120136418 | NEUROMODULATION CRYOTHERAPEUTIC DEVICES AND ASSOCIATED SYSTEMS AND METHODS - Neuromodulation cryotherapeutic devices and associated systems and methods are disclosed herein. A cryotherapeutic device configured in accordance with a particular embodiment of the present technology can include an elongated shaft having distal portion and a supply lumen along at least a portion of the shaft. The shaft can be configured to locate the distal portion intravascularly at a treatment site proximate a renal artery or renal ostium. The supply lumen can be configured to receive a liquid refrigerant. The cryotherapeutic device can further include a cooling assembly at the distal portion of the shaft. The cooling assembly can include an applicator in fluid communication with the supply lumen and configured to deliver cryotherapeutic cooling to nerves proximate the target site when the cooling assembly is in a deployed state. | 05-31-2012 |
Naomi Buckley, Galway City IE
| Patent application number | Description | Published |
|---|---|---|
| 20120130360 | NEUROMODULATION CRYOTHERAPEUTIC DEVICES AND ASSOCIATED SYSTEMS AND METHODS - Neuromodulation cryotherapeutic devices and associated systems and methods are disclosed herein. A cryotherapeutic device configured in accordance with a particular embodiment of the present technology can include an elongated shaft having distal portion and a supply lumen along at least a portion of the shaft. The shaft can be configured to locate the distal portion intravascularly at a treatment site proximate a renal artery or renal ostium. The supply lumen can be configured to receive a liquid refrigerant. The cryotherapeutic device can further include a cooling assembly at the distal portion of the shaft. The cooling assembly can include an applicator in fluid communication with the supply lumen and configured to deliver cryotherapeutic cooling to nerves proximate the target site when the cooling assembly is in a deployed state. | 05-24-2012 |
| 20120136417 | NEUROMODULATION CRYOTHERAPEUTIC DEVICES AND ASSOCIATED SYSTEMS AND METHODS - Neuromodulation cryotherapeutic devices and associated systems and methods are disclosed herein. A cryotherapeutic device configured in accordance with a particular embodiment of the present technology can include an elongated shaft having distal portion and a supply lumen along at least a portion of the shaft. The shaft can be configured to locate the distal portion intravascularly at a treatment site proximate a renal artery or renal ostium. The supply lumen can be configured to receive a liquid refrigerant. The cryotherapeutic device can further include a cooling assembly at the distal portion of the shaft. The cooling assembly can include an applicator in fluid communication with the supply lumen and configured to deliver cryotherapeutic cooling to nerves proximate the target site when the cooling assembly is in a deployed state. | 05-31-2012 |
Noel Buckley, Vancouver CA
| Patent application number | Description | Published |
|---|---|---|
| 20080258427 | REAR SUSPENSION SYSTEM FOR BICYCLES - This application relates to rear suspension system for bicycles, such as freeride, downhill and trail-style mountain bikes. The suspension system includes a rear suspension for coupling the rear wheel of the bicycle to the bicycle frame, a rear shock absorber disposed entirely in front of the seat tube of the frame and a linkage for operatively coupling the rear suspension to the rear shock absorber. The linkage intersects the longitudinal axis of the seat tube for transmitting rear suspension forces around the seat tube to the rear shock absorber. The seat tube is preferably continuous and is disposed so that the bicycle seat is adjustable over a full range of seat positions. The seat tube orientation ensures that the seat is movable between optimum biomechanical positions for both uphill pedaling and aggressive downhill freeriding. Additionally, the seat tube and rear suspension system are configured so that the rear wheel and rear suspension will not contact the seat tube, seat, or bicycle rider even when the rear suspension system is in a fully compressed, forward position. The shock absorber is preferably oriented in an orientation to maximize its stroke length. For example, the shock absorber may be oriented generally parallel to a top tube of the bicycle frame. | 10-23-2008 |
| 20110233893 | REAR SUSPENSION SYSTEM FOR BICYCLES - A rear suspension system for bicycles, such as freeride, downhill and trail-style mountain bikes. The suspension system includes a rear suspension for coupling the rear wheel of the bicycle to the bicycle frame, a rear shock absorber disposed entirely in front of the seat tube of the frame and a linkage for operatively coupling the rear suspension to the rear shock absorber. The linkage intersects the longitudinal axis of the seat tube for transmitting rear suspension forces around the seat tube to the rear shock absorber. The seat tube is preferably continuous and is disposed so that the bicycle seat is adjustable over a full range of seat positions. Additionally, the seat tube and rear suspension system are configured so that the rear wheel and rear suspension will not contact the seat tube, seat, or bicycle rider even when the rear suspension system is in a fully compressed, forward position. | 09-29-2011 |
Paul Fleming Buckley, Auckland NZ
| Patent application number | Description | Published |
|---|---|---|
| 20110315716 | FLUID DISPENSER AND A METHOD FOR ITS USE - A valve operating mechanism for use in a fluid dispenser is described, wherein the fluid dispenser includes a reservoir for a fluid to be delivered, a fluid outlet for the reservoir, a piston configured to move through the reservoir, and an actuator for the piston, the valve operating mechanism including a valve, wherein the valve has an upstream side and a downstream side, and in at least one point of operation of the valve operating mechanism, the valve is inoperable as a consequence of the pressure difference between the upstream side of the valve and the downstream side of the valve. | 12-29-2011 |
Robin Andrew Buckley, Ottawa CA
| Patent application number | Description | Published |
|---|---|---|
| 20100150512 | WAVEGUIDE FOR PROPAGATING RADIATION - A low-loss waveguide that can be curved aggressively, that is, curved with a radius of curvature that is substantially zero, in the plane of propagation, without radiating, is formed by a slab of dielectric material having four metal plates, two on each opposite surface of the slab and mutually spaced to define in the dielectric slab between the four metal plates a confinement zone. In use, electromagnetic radiation injected in one end of the zone by suitable input means will propagate throughout the zone to an extraction means. Lower loss and better confinement of the radiation may be obtained by providing plugs of dielectric material adjacent the inwardly-facing edge of each of the metal plates. Embodiments of the invention can be used to implement integrated optical devices and circuits for routing or processing light signals. | 06-17-2010 |
Shannon Buckley, Leuven BE
| Patent application number | Description | Published |
|---|---|---|
| 20080311084 | Mapc Engraftment in the Hematopoietic System - The present invention relates to MAPCs and progeny derived therefrom to provide lymphohematopoietic cells in a tissue of the lymphohematopoietic system of a subject. | 12-18-2008 |